- In January 2023, AmerisourceBergen Corporation completed its acquisition of PharmaLex Holding GmbH, a leading provider of regulatory and other services in the life sciences industry, which significantly expanded AmerisourceBergen’s service portfolio in a key market
- In August 2022, PharmaLex Group merged with Finland-based DRA Consulting, a consulting firm specializing in pharmacovigilance, market access, quality and manufacturing, regulatory services, and more, bringing comprehensive service solutions to PharmaLex’s offerings with over 300 clients
- In April 2022, VCLS entered into a partnership with EC Innovations, a global Chinese translation service provider experienced in translating highly regulated medical and life sciences content, which strengthened VCLS’s capabilities and broadened its service offerings
- In December 2021, Thermo Fisher Scientific Inc. completed its acquisition of PPD, Inc., a prominent service provider in the biotech and biopharma industries, integrating PPD into Thermo Fisher’s Laboratory Products and Services unit and broadening the company’s reach in clinical development, covering areas from scientific discovery to therapeutics production
- In December 2021, Labcorp finalized its acquisition of Toxikon Corporation, a contract research organization specializing in nonclinical testing services, enhancing Labcorp’s nonclinical development portfolio and solidifying its position as a strategic partner for pharmaceutical and biotechnology clients
